Advanced Therapy Medicinal Products CDMO Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Gene Therapy, Cell Therapy, Tissue Engineered, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By Indication
The Advanced Therapy Medicinal Products CDMO Market is valued at USD 6.49 billion in 2025 and is projected to grow at a CAGR of 15.8% to reach USD 24.3 billion by 2034. Advanced Therapy Medicinal ... もっと見る
※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
|
|
Summary The Advanced Therapy Medicinal Products CDMO Market is valued at USD 6.49 billion in 2025 and is projected to grow at a CAGR of 15.8% to reach USD 24.3 billion by 2034. Advanced Therapy Medicinal Products CDMO MarketThe ATMP CDMO market serves developers of cell, gene, and tissue-engineered therapies with end-to-end services spanning process and analytical development, GMP manufacturing, quality control/release, fill-finish, cryo-logistics, and post-approval lifecycle support. Core applications include autologous and allogeneic cell therapies (CAR-T, TCR-T, NK, MSC), in vivo and ex vivo gene therapies (AAV, lentiviral, non-viral), oncolytic viruses, plasmid DNA and mRNA starting materials, and tissue/skin substitutes. Adoption is propelled by expanding clinical pipelines, expedited regulatory pathways, and maturing commercial launches requiring global tech transfer, multi-site comparability, and reliable supply at commercial scale. Key trends include platformization of viral vectors and closed cell-processing systems, modular single-use facilities to accelerate capacity deployment, intensified MSAT (manufacturing science and technology) to lock processes earlier, and digitalization (eBR/QMS/LIMS, scheduling and vein-to-vein orchestration). Buyers increasingly seek multiservice partners able to provide PD-to-commercial continuity, integrated raw-material strategy (plasmids, enzymes, resins), and global QP/QC release footprints. Competitive dynamics span large, diversified CDMOs scaling multi-modal campuses; specialist viral-vector and cell-processing players; and hospital-embedded manufacturers partnering for late-stage scale-up. Differentiation rests on right-first-time tech transfer, robust potency/identity assays, aseptic mastery in small-volume high-value batches, and network resilience under strict cold-chain constraints. Challenges include highly variable COGS, batch-to-batch variability, raw-material scarcity, skilled talent shortages, sterility/release testing lead times, and evolving global regulations that complicate multi-region comparability. CDMOs that combine platform know-how with flexible capacity, rigorous analytics, and digital/operational excellence are best positioned as sponsors move from bespoke pilots to reproducible, inspection-ready commercial supply. Advanced Therapy Medicinal Products CDMO Market Key Insights• Platform processes compress timelines
Standardized unit operations - upstream vector production, closed cell expansion, and templated purification - reduce PD cycles and de-risk tech transfer. Libraries of qualified raw materials and assays further speed readiness.
• Allogeneic scale favors industrialized suites
Suspension cell lines, higher-titer vectors, and large-format bioreactors enable batch economies. CDMOs with parallel, identical suites and strong supply planning win late-stage programs.
• Autologous demands vein-to-vein orchestration
Slotting, chain-of-identity, and cryo-logistics are as critical as sterility. Digital scheduling, eBR, and real-time temperature/location monitoring cut failures and unlock site expansion.
• Analytics and potency are the gating items
Phase advancement hinges on qualified potency, identity, and residuals assays. In-house method development/validation and rapid sterility alternatives reduce release bottlenecks.
• Vector capacity and quality drive gene therapy
AAV/LVV platforms with high yields, improved capsid integrity, and consistent full/empty ratios differentiate. Stable producer cell lines and intensified purification reduce COGS volatility.
• Closed systems and automation reduce risk
Isolators, single-use flows, and automated cell washers/transfection steps shrink contamination risk and operator variability. Human-error reduction is a measurable procurement criterion.
• MSAT and comparability expertise win tech transfers
DoE, scale-down models, and structured PPQ strategies enable rapid site adds and global launches. Clear change-control and PPQ packages support inspections and filings.
• Regulatory fluency is a core service
Experience across FDA, EMA, MHRA, PMDA, and NMPA expedites CMC alignment. QP release networks and coherent global submission support ease multi-region commercialization.
• Raw-material and supplier strategy matters
Vertical links for plasmids, critical enzymes, resins, and bags/tubing stabilize lead times. Second-source qualification and safety stocks mitigate shocks without excessive working capital.
• Flexible business models attract biotechs
Phase-appropriate pricing, capacity reservations, success-based milestones, and co-investment in bespoke suites align incentives. Transparent slot governance builds long-term partnerships. Advanced Therapy Medicinal Products CDMO Market Reginal AnalysisNorth America Largest concentration of ATMP sponsors and clinical trials, with strong demand for end-to-end cell and vector services. Buyers prioritize rapid PD-to-GMP transitions, digital eBR/LIMS integration, and inspection readiness. State incentives and workforce programs support capacity builds; hospital manufacturing collaborates with CDMOs for commercial scale and multi-state distribution. Europe Robust regulatory framework for ATMPs and QP release drives demand for analytics, method validation, and comparability packages. Public-private innovation clusters anchor viral-vector and cell-therapy hubs. Hospital exemption coexists with CDMO partnerships for late-stage supply; tenders weigh sustainability, batch documentation quality, and multi-language QMS maturity. Asia-Pacific Japan and Korea lead in commercial cell therapies; Australia offers agile early-phase pathways; China scales vector and cell-processing capacity with rapid site approvals. Sponsors seek bilingual tech-transfer teams, localized raw-material sourcing, and regional release testing. Partnerships with academic GMP centers feed CDMO pipelines. Middle East & Africa Emerging ATMP interest centered on GCC innovation districts and specialty hospitals. Buyers favor modular cleanrooms, turnkey training, and distributor-backed cold chain. Early programs import vectors while building localized fill-finish and QC; government initiatives encourage tech transfer and skills development. South & Central America Growing early-phase activity concentrates in major research hospitals and private networks. CDMO opportunities include plasmid/mRNA starting materials, small-scale cell processing, and QC services. Currency and import dynamics favor regional partnerships, phased capacity, and robust tech-transfer playbooks with bilingual documentation. Advanced Therapy Medicinal Products CDMO Market SegmentationBy Product Gene Therapy Cell Therapy Tissue Engineered Others
By Phase Phase I Phase II Phase III Phase IV
By Indication Oncology Cardiology Central nervous system Musculoskeletal Infectious disease Dermatology Endocrine metabolic genetic Immunology & inflammation Ophthalmology Hematology Gastroenterology Others
Key Market playersLonza, Catalent (Cell & Gene Therapy), Thermo Fisher Scientific (Viral Vector & Cell Therapy Services), FUJIFILM Diosynth Biotechnologies, WuXi Advanced Therapies, AGC Biologics, Oxford Biomedica, Minaris Regenerative Medicine, Resilience (National Resilience), Center for Breakthrough Medicines (CBM), Recipharm (including Yposkesi), Viralgen Vector Core, Halix B.V., Charles River Laboratories (Cognate BioServices), Porton AdvancedAdvanced Therapy Medicinal Products CDMO Market Analytics
The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modelling, to assess supply–demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends.
Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behaviour are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.
Advanced Therapy Medicinal Products CDMO Market Competitive Intelligence
The competitive landscape is mapped through OG Analysis’ proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption.
Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.
Countries Covered
- North America — Advanced Therapy Medicinal Products CDMO market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe — Advanced Therapy Medicinal Products CDMO market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- BeNeLux
- Russia
- Sweden
- Asia-Pacific — Advanced Therapy Medicinal Products CDMO market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa — Advanced Therapy Medicinal Products CDMO market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America — Advanced Therapy Medicinal Products CDMO market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
* We can include data and analysis of additional countries on demand.
Research Methodology
This study combines primary inputs from industry experts across the Advanced Therapy Medicinal Products CDMO value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.
Key Questions Addressed
What is the current and forecast market size of the Advanced Therapy Medicinal Products CDMO industry at global, regional, and country levels?
Which types, applications, and technologies present the highest growth potential?
How are supply chains adapting to geopolitical and economic shocks?
What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?
Who are the leading players, and how are their strategies evolving in the face of global uncertainty?
Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?
Where are the most investable opportunities—across technology roadmaps, sustainability-linked innovation, and M&A—and what is the best segment to invest over the next 3–5 years?
Your Key Takeaways from the Advanced Therapy Medicinal Products CDMO Market Report
- Global Advanced Therapy Medicinal Products CDMO market size and growth projections (CAGR), 2024-2034
- Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Advanced Therapy Medicinal Products CDMO trade, costs, and supply chains
- Advanced Therapy Medicinal Products CDMO market size, share, and outlook across 5 regions and 27 countries, 2023-2034
- Advanced Therapy Medicinal Products CDMO market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
- Short- and long-term Advanced Therapy Medicinal Products CDMO market trends, drivers, restraints, and opportunities
- Porter’s Five Forces analysis, technological developments, and Advanced Therapy Medicinal Products CDMO supply chain analysis
- Advanced Therapy Medicinal Products CDMO trade analysis, Advanced Therapy Medicinal Products CDMO market price analysis, and Advanced Therapy Medicinal Products CDMO supply/demand dynamics
- Profiles of 5 leading companies—overview, key strategies, financials, and products
- Latest Advanced Therapy Medicinal Products CDMO market news and developments
Additional Support
With the purchase of this report, you will receive
- An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
- Complimentary report update to incorporate the latest available data and the impact of recent market developments.
* The updated report will be delivered within 3 working days"
ページTOPに戻る
Table of Contents 1. Table of Contents
1.1 List of Tables
1.2 List of Figures
2. Global Advanced Therapy Medicinal Products CDMO Market Summary, 2025
2.1 Advanced Therapy Medicinal Products CDMO Industry Overview
2.1.1 Global Advanced Therapy Medicinal Products CDMO Market Revenues (In US$ billion)
2.2 Advanced Therapy Medicinal Products CDMO Market Scope
2.3 Research Methodology
3. Advanced Therapy Medicinal Products CDMO Market Insights, 2024-2034
3.1 Advanced Therapy Medicinal Products CDMO Market Drivers
3.2 Advanced Therapy Medicinal Products CDMO Market Restraints
3.3 Advanced Therapy Medicinal Products CDMO Market Opportunities
3.4 Advanced Therapy Medicinal Products CDMO Market Challenges
3.5 Tariff Impact on Global Advanced Therapy Medicinal Products CDMO Supply Chain Patterns
4. Advanced Therapy Medicinal Products CDMO Market Analytics
4.1 Advanced Therapy Medicinal Products CDMO Market Size and Share, Key Products, 2025 Vs 2034
4.2 Advanced Therapy Medicinal Products CDMO Market Size and Share, Dominant Applications, 2025 Vs 2034
4.3 Advanced Therapy Medicinal Products CDMO Market Size and Share, Leading End Uses, 2025 Vs 2034
4.4 Advanced Therapy Medicinal Products CDMO Market Size and Share, High Growth Countries, 2025 Vs 2034
4.5 Five Forces Analysis for Global Advanced Therapy Medicinal Products CDMO Market
4.5.1 Advanced Therapy Medicinal Products CDMO Industry Attractiveness Index, 2025
4.5.2 Advanced Therapy Medicinal Products CDMO Supplier Intelligence
4.5.3 Advanced Therapy Medicinal Products CDMO Buyer Intelligence
4.5.4 Advanced Therapy Medicinal Products CDMO Competition Intelligence
4.5.5 Advanced Therapy Medicinal Products CDMO Product Alternatives and Substitutes Intelligence
4.5.6 Advanced Therapy Medicinal Products CDMO Market Entry Intelligence
5. Global Advanced Therapy Medicinal Products CDMO Market Statistics – Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2034
5.1 World Advanced Therapy Medicinal Products CDMO Market Size, Potential and Growth Outlook, 2024- 2034 ($ billion)
5.1 Global Advanced Therapy Medicinal Products CDMO Sales Outlook and CAGR Growth By Product, 2024- 2034 ($ billion)
5.2 Global Advanced Therapy Medicinal Products CDMO Sales Outlook and CAGR Growth By Phase, 2024- 2034 ($ billion)
5.3 Global Advanced Therapy Medicinal Products CDMO Sales Outlook and CAGR Growth By Indication, 2024- 2034 ($ billion)
5.4 Global Advanced Therapy Medicinal Products CDMO Market Sales Outlook and Growth by Region, 2024- 2034 ($ billion)
6. Asia Pacific Advanced Therapy Medicinal Products CDMO Industry Statistics – Market Size, Share, Competition and Outlook
6.1 Asia Pacific Advanced Therapy Medicinal Products CDMO Market Insights, 2025
6.2 Asia Pacific Advanced Therapy Medicinal Products CDMO Market Revenue Forecast By Product, 2024- 2034 (USD billion)
6.3 Asia Pacific Advanced Therapy Medicinal Products CDMO Market Revenue Forecast By Phase, 2024- 2034 (USD billion)
6.4 Asia Pacific Advanced Therapy Medicinal Products CDMO Market Revenue Forecast By Indication, 2024- 2034 (USD billion)
6.5 Asia Pacific Advanced Therapy Medicinal Products CDMO Market Revenue Forecast by Country, 2024- 2034 (USD billion)
6.5.1 China Advanced Therapy Medicinal Products CDMO Market Size, Opportunities, Growth 2024- 2034
6.5.2 India Advanced Therapy Medicinal Products CDMO Market Size, Opportunities, Growth 2024- 2034
6.5.3 Japan Advanced Therapy Medicinal Products CDMO Market Size, Opportunities, Growth 2024- 2034
6.5.4 Australia Advanced Therapy Medicinal Products CDMO Market Size, Opportunities, Growth 2024- 2034
7. Europe Advanced Therapy Medicinal Products CDMO Market Data, Penetration, and Business Prospects to 2034
7.1 Europe Advanced Therapy Medicinal Products CDMO Market Key Findings, 2025
7.2 Europe Advanced Therapy Medicinal Products CDMO Market Size and Percentage Breakdown By Product, 2024- 2034 (USD billion)
7.3 Europe Advanced Therapy Medicinal Products CDMO Market Size and Percentage Breakdown By Phase, 2024- 2034 (USD billion)
7.4 Europe Advanced Therapy Medicinal Products CDMO Market Size and Percentage Breakdown By Indication, 2024- 2034 (USD billion)
7.5 Europe Advanced Therapy Medicinal Products CDMO Market Size and Percentage Breakdown by Country, 2024- 2034 (USD billion)
7.5.1 Germany Advanced Therapy Medicinal Products CDMO Market Size, Trends, Growth Outlook to 2034
7.5.2 United Kingdom Advanced Therapy Medicinal Products CDMO Market Size, Trends, Growth Outlook to 2034
7.5.2 France Advanced Therapy Medicinal Products CDMO Market Size, Trends, Growth Outlook to 2034
7.5.2 Italy Advanced Therapy Medicinal Products CDMO Market Size, Trends, Growth Outlook to 2034
7.5.2 Spain Advanced Therapy Medicinal Products CDMO Market Size, Trends, Growth Outlook to 2034
8. North America Advanced Therapy Medicinal Products CDMO Market Size, Growth Trends, and Future Prospects to 2034
8.1 North America Snapshot, 2025
8.2 North America Advanced Therapy Medicinal Products CDMO Market Analysis and Outlook By Product, 2024- 2034 ($ billion)
8.3 North America Advanced Therapy Medicinal Products CDMO Market Analysis and Outlook By Phase, 2024- 2034 ($ billion)
8.4 North America Advanced Therapy Medicinal Products CDMO Market Analysis and Outlook By Indication, 2024- 2034 ($ billion)
8.5 North America Advanced Therapy Medicinal Products CDMO Market Analysis and Outlook by Country, 2024- 2034 ($ billion)
8.5.1 United States Advanced Therapy Medicinal Products CDMO Market Size, Share, Growth Trends and Forecast, 2024- 2034
8.5.1 Canada Advanced Therapy Medicinal Products CDMO Market Size, Share, Growth Trends and Forecast, 2024- 2034
8.5.1 Mexico Advanced Therapy Medicinal Products CDMO Market Size, Share, Growth Trends and Forecast, 2024- 2034
9. South and Central America Advanced Therapy Medicinal Products CDMO Market Drivers, Challenges, and Future Prospects
9.1 Latin America Advanced Therapy Medicinal Products CDMO Market Data, 2025
9.2 Latin America Advanced Therapy Medicinal Products CDMO Market Future By Product, 2024- 2034 ($ billion)
9.3 Latin America Advanced Therapy Medicinal Products CDMO Market Future By Phase, 2024- 2034 ($ billion)
9.4 Latin America Advanced Therapy Medicinal Products CDMO Market Future By Indication, 2024- 2034 ($ billion)
9.5 Latin America Advanced Therapy Medicinal Products CDMO Market Future by Country, 2024- 2034 ($ billion)
9.5.1 Brazil Advanced Therapy Medicinal Products CDMO Market Size, Share and Opportunities to 2034
9.5.2 Argentina Advanced Therapy Medicinal Products CDMO Market Size, Share and Opportunities to 2034
10. Middle East Africa Advanced Therapy Medicinal Products CDMO Market Outlook and Growth Prospects
10.1 Middle East Africa Overview, 2025
10.2 Middle East Africa Advanced Therapy Medicinal Products CDMO Market Statistics By Product, 2024- 2034 (USD billion)
10.3 Middle East Africa Advanced Therapy Medicinal Products CDMO Market Statistics By Phase, 2024- 2034 (USD billion)
10.4 Middle East Africa Advanced Therapy Medicinal Products CDMO Market Statistics By Indication, 2024- 2034 (USD billion)
10.5 Middle East Africa Advanced Therapy Medicinal Products CDMO Market Statistics by Country, 2024- 2034 (USD billion)
10.5.1 Middle East Advanced Therapy Medicinal Products CDMO Market Value, Trends, Growth Forecasts to 2034
10.5.2 Africa Advanced Therapy Medicinal Products CDMO Market Value, Trends, Growth Forecasts to 2034
11. Advanced Therapy Medicinal Products CDMO Market Structure and Competitive Landscape
11.1 Key Companies in Advanced Therapy Medicinal Products CDMO Industry
11.2 Advanced Therapy Medicinal Products CDMO Business Overview
11.3 Advanced Therapy Medicinal Products CDMO Product Portfolio Analysis
11.4 Financial Analysis
11.5 SWOT Analysis
12 Appendix
12.1 Global Advanced Therapy Medicinal Products CDMO Market Volume (Tons)
12.1 Global Advanced Therapy Medicinal Products CDMO Trade and Price Analysis
12.2 Advanced Therapy Medicinal Products CDMO Parent Market and Other Relevant Analysis
12.3 Publisher Expertise
12.2 Advanced Therapy Medicinal Products CDMO Industry Report Sources and Methodology
ページTOPに戻る
- CHPTAC Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Paper, Textile, Oil and Gas, Personal Care, Water Treatment, Others), By Application (Emulsifiers, Surfactants, Flocculants, Binding Agents, Cationic Agent)
- Wellness Tonics Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Enhanced Water, Energy Shots, Kombucha, Others), By Application (Online, Offline)
- Elastomers Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (SBR (Styrene block copolymers), IIR (Butyl Elastomer), NBR (Nitrile Elastomer), ACM (Acrylic Elastomer), EPM (Ethylene-propylene Elastomer), PEBA (Thermoplastic polyether block amides), SBC (Styrene block copolymers), TPO (Thermoplastic Polyolefin), TPU (Thermoplastic Polyurethanes), TPV (Thermoplastic Vulcanizates)), By Application (Automotive, Consumer Goods, Medical, Industrial, Others)
- Chloroacetyl Chloride Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Chlorination of Acetyl Chloride, Oxidation of 1, 1-Dichloroethylene, Others), By Application (Herbicides, Active Pharmaceutical Ingredients (APIs), Chemical Production)
- Metal Shim Market Outlook 2026-2034: Market Share, and Growth Analysis By Material (Aluminum, Stainless Steel, Brass, Copper, Plastic, Others), By Product (Slotted Shim, Shim Stock/Sheet, Arbor Shim, Custom Shim, Others), By Application
- Zhug Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Red Zhug, Green Zhug), By Application (Retails, Foodservices)
- Retrieval Augmented Generation market Outlook 2026-2034: Market Share, and Growth Analysis By Function (Document Retrieval, Response Generation, Summarization & Reporting, Recommendation Engines), By Application (Knowledge Management, Customer Support & Chatbots, Legal & Compliance, Marketing & Sales, Research & Development, Content Generation), By Deployment, By End-User
- Irrigation Pump Market Outlook 2026-2034: Market Share, and Growth Analysis By Maximum Capacity (Up to 500m3/H Pump, 500 to 1000m3/H Pump, 1000m3/H Pump and above), By Power (Electric, Hydraulic, Pneumatic), By Application, By Fuel
- Potassium Formate Market Outlook 2026-2034: Market Share, and Growth Analysis By Form (Liquid/Brine, Powder), By Application (Deicing Agent, Drilling & Completion Fluids, Fertilizer Additives, Heat Transfer Fluids, Preservatives, Others), By End-User
- Cloud-Based Water Treatment Monitoring Market Outlook 2026-2034: Market Share, and Growth Analysis By Service Model (Software-as-a-Service (SaaS), Platform-as-a-Service (PaaS), Infrastructure-as-a-Service (IaaS)), By Application (Real-Time Process Monitoring & Control, Water Quality & Compliance Management, Asset Performance & Predictive Maintenance, Energy Management & Optimization, Chemical Feed & Dosing Control, Data Analytics & Reporting, Remote Operations Management), By End-User, By Deployment Type, By Component
-
CHPTAC Market Outlook 2026-2034: Market Share, and Growth Analysis By Product (Paper, Textile, Oil and Gas, Personal Care, Water Treatment, Others), By Application (Emulsifiers, Surfactants, Flocculants, Binding Agents, Cationic Agent)
-
Wellness Tonics Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Enhanced Water, Energy Shots, Kombucha, Others), By Application (Online, Offline)
-
Elastomers Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (SBR (Styrene block copolymers), IIR (Butyl Elastomer), NBR (Nitrile Elastomer), ACM (Acrylic Elastomer), EPM (Ethylene-propylene Elastomer), PEBA (Thermoplastic polyether block amides), SBC (Styrene block copolymers), TPO (Thermoplastic Polyolefin), TPU (Thermoplastic Polyurethanes), TPV (Thermoplastic Vulcanizates)), By Application (Automotive, Consumer Goods, Medical, Industrial, Others)
-
Chloroacetyl Chloride Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Chlorination of Acetyl Chloride, Oxidation of 1, 1-Dichloroethylene, Others), By Application (Herbicides, Active Pharmaceutical Ingredients (APIs), Chemical Production)
-
Metal Shim Market Outlook 2026-2034: Market Share, and Growth Analysis By Material (Aluminum, Stainless Steel, Brass, Copper, Plastic, Others), By Product (Slotted Shim, Shim Stock/Sheet, Arbor Shim, Custom Shim, Others), By Application
-
Zhug Market Outlook 2026-2034: Market Share, and Growth Analysis By Type (Red Zhug, Green Zhug), By Application (Retails, Foodservices)
-
Retrieval Augmented Generation market Outlook 2026-2034: Market Share, and Growth Analysis By Function (Document Retrieval, Response Generation, Summarization & Reporting, Recommendation Engines), By Application (Knowledge Management, Customer Support & Chatbots, Legal & Compliance, Marketing & Sales, Research & Development, Content Generation), By Deployment, By End-User
-
Irrigation Pump Market Outlook 2026-2034: Market Share, and Growth Analysis By Maximum Capacity (Up to 500m3/H Pump, 500 to 1000m3/H Pump, 1000m3/H Pump and above), By Power (Electric, Hydraulic, Pneumatic), By Application, By Fuel
-
Potassium Formate Market Outlook 2026-2034: Market Share, and Growth Analysis By Form (Liquid/Brine, Powder), By Application (Deicing Agent, Drilling & Completion Fluids, Fertilizer Additives, Heat Transfer Fluids, Preservatives, Others), By End-User
-
Cloud-Based Water Treatment Monitoring Market Outlook 2026-2034: Market Share, and Growth Analysis By Service Model (Software-as-a-Service (SaaS), Platform-as-a-Service (PaaS), Infrastructure-as-a-Service (IaaS)), By Application (Real-Time Process Monitoring & Control, Water Quality & Compliance Management, Asset Performance & Predictive Maintenance, Energy Management & Optimization, Chemical Feed & Dosing Control, Data Analytics & Reporting, Remote Operations Management), By End-User, By Deployment Type, By Component
- 本レポートと同じKEY WORDの最新刊レポートはありません。
よくあるご質問
OG Analysis社はどのような調査会社ですか?
OG Analysisは、10年以上の専門知識を持ち、半導体、エネルギー、化学品、自動車、農業など多様な市場調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行っています。 もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
